An Open-Label, Dose-Escalation Study of AZD2461

Clinical trial NCT01247168 · COMPLETED

Trial details

NCT number: NCT01247168
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Solid Tumors Cancer Tumor

Start date: 2010-11-01
Primary completion: 2011-05-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.